Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
La Revue De Medecine Interne
|
January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults: principles, realization and application to the treatment of germ cell, trophoblastic, breast, ovarian and small-cell bronchial tumors. 1]
J P Lotz, F Pene, C Bouleuc, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique
L Dal Cortivo, P H Cottu, J P Lotz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant alpha-2b interferon and doxorubicin: results of a pilot study
J P Lotz, J D Grange, L Hannoun, et al.
Cancer
|
June 15, 1996
Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma
J P Lotz, C Bouleuc, T André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors
C Theodore, C Chevreau, Y Yataqhene, et al.
La Revue De Medecine Interne
|
January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults. Principles, realization, and application to the treatment of germinal, trophoblastic, breast, ovarian and small-cell bronchial tumors. 2]
J P Lotz, F Pene, C Bouleuc, et al.
Bone Marrow Transplantation
|
September 1, 1996
The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease
J P Lotz, T André, C Bouleuc, et al.
British Journal of Cancer
|
January 26, 2006
Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients
L Moureau-Zabotto, S Ricci, J P Lefranc, et al.
European Journal of Haematology. Supplementum
|
January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia
D Machover, J Gastiaburu, M Delgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
J A Ledermann, R Herd, D Maraninchi, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
La Revue De Medecine Interne
|
January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults: principles, realization and application to the treatment of germ cell, trophoblastic, breast, ovarian and small-cell bronchial tumors. 1]
J P Lotz, F Pene, C Bouleuc, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique
L Dal Cortivo, P H Cottu, J P Lotz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant alpha-2b interferon and doxorubicin: results of a pilot study
J P Lotz, J D Grange, L Hannoun, et al.
Cancer
|
June 15, 1996
Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma
J P Lotz, C Bouleuc, T André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors
C Theodore, C Chevreau, Y Yataqhene, et al.
La Revue De Medecine Interne
|
January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults. Principles, realization, and application to the treatment of germinal, trophoblastic, breast, ovarian and small-cell bronchial tumors. 2]
J P Lotz, F Pene, C Bouleuc, et al.
Bone Marrow Transplantation
|
September 1, 1996
The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease
J P Lotz, T André, C Bouleuc, et al.
British Journal of Cancer
|
January 26, 2006
Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients
L Moureau-Zabotto, S Ricci, J P Lefranc, et al.
European Journal of Haematology. Supplementum
|
January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia
D Machover, J Gastiaburu, M Delgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
J A Ledermann, R Herd, D Maraninchi, et al.
Page
of 9